abc-logo
  • Latest Articles
  • Diseases
    • Autoimmune Diseases
      • Arthritis
      • Crohn's Disease
      • Juvenile Arthritis
      • Lupus
      • Rheumatoid Arthritis
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Cancer
      • Destroying the Cancer Threat
      • Myeloma
      • Leukemia
      • Lymphoma
      • Breast Cancer
      • Cervical Cancer
      • Brain Cancer
      • Colon Cancer
      • Kidney Cancer
      • Stomach Cancer
      • Lung Cancer
      • Skin Cancer
    • Heart Diseases
      • Heart Transplant
      • Heart Disease
      • High Cholesterol
      • Obesity
    • Infectious Diseases
      • Coronavirus
      • HIV/AIDS
      • Hepatitis C
      • HPV
    • Mental Health
      • Depression
      • Schizophrenia
      • Bipolar Disorder
    • Neurological Diseases
      • ALS
      • Alzheimer's
      • Epilepsy
      • Migraine
      • Multiple Sclerosis
      • Parkinson's
    • Treatment Approaches
      • Genomics
      • Vaccines
      • Immunologic
      • Treatments
  • About Us
    • Our Commitment
      • Development Pipeline
      • Innovation Fragility
      • Innovation Offsets
      • Accessibility & Affordability
      • R&D Commitment
    • Faces of Innovation
      • Champions / Advocates
      • Patient Profiles
      • Researcher Profiles
    • Member Companies
      • Who We Are
    • Campaigns
      • Breakthrough
      • Together
      • Do Not Go Gentle
      • New World
      • Cells
      • New Era of Medicine
    • Collaboration & Events
      • Events
  • SEARCH
  •  STAY AHEAD
  • Take Action
Recognizing Diversity in Clinical Trials image
  1. Home
  2. About Us
  3. Our Commitment
  4. Clinical Trials
  5. Recognizing Diversity in Clinical Trials

Recognizing Diversity in Clinical Trials

Clinical Trials
Advocacy / Policy
Pfizer
R&D Commitment

Every time you take a medicine – even if it’s just for a headache – you are benefitting from the results of a clinical trial. By the time a medicine reaches the pharmacy counter, it has withstood rigorous testing to ensure safety and efficacy.

 

The clinical trials process is lengthy and complex, relying heavily on volunteer participation, and without these volunteers, the development of new medicines would not be possible.

Clinical Trial Infographic image
Clinical Trial Infographic image

However, groups such as African Americans, Asian Americans and Hispanics are significantly underrepresented in clinical research. According to the U.S. Food & Drug Administration, African Americans represent 12 percent of the U.S. population but only 5 percent of clinical trial participants and Hispanics make up 16 percent of the population but only 1 percent of clinical trial participants. It is important to identify barriers to enrollment of demographic subgroups in clinical trials and employ strategies to encourage greater participation.

 

Inclusion of individuals of varied races, ethnicities, ages, and sex/gender in clinical trials can help to improve the completeness and quality of demographic subgroup data reporting and analysis, and make demographic subgroup data more available and transparent for health care providers and patients. This is vital, given that certain demographic subgroups of patient populations can respond differently to therapies.

Diversity in clinical trials can help researchers find better ways to fight diseases.

 

 

Biopharmaceutical companies, academia and other stakeholders have been working to increase diversity in clinical trials. In order to understand how a treatment affects a patient population, it is important to find volunteer participants from all backgrounds. To find out more about clinical trials, click here.


RELATED TOPICS

Clinical Trials
Advocacy / Policy
Pfizer
R&D Commitment

Share:

  • #GoBoldly

Explore the innovative research and technological breakthroughs of America's biopharmaceutical industry, and get to know the people behind the fight to prevent, treat and cure disease.

abc-logo
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.

  • DISEASES
  • Cancer
  • Heart Diseases
  • Infectious Diseases
  • Autoimmune Diseases
  • Mental Health
  • Neurological Diseases
  • Treatment Approaches

  • Take Action

  • About Us
  • Collaboration & Events
  • Our Commitment
  • Member Companies
  • Campaigns
  • Faces of Innovation
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.